Literature DB >> 2484703

Relaxations to SIN-1, nitric oxide, and sodium nitroprusside in canine arteries and veins.

V M Miller1, P M Vanhoutte.   

Abstract

Experiments were designed to compare the vasodilator properties of SIN-1, the active metabolite of molsidomine, with nitric oxide (NO) and sodium nitroprusside. Rings of canine femoral arteries and veins with and without endothelium were suspended in organ chambers for the measurement of isometric force. SIN-1 and sodium nitroprusside relaxed rings of blood vessels in the presence and in the absence of the endothelium. However, these relaxations were reduced by the endothelial cells in arteries contracted with endothelin and in veins contracted with prostaglandin F2 alpha. In the arteries, SIN-1, sodium nitroprusside, and NO were equipotent in relaxing rings without endothelium contracted with either norepinephrine or prostaglandin F2 alpha; NO was less potent than the other two vasodilators when the arteries were contracted with endothelin. In the veins without endothelium, the potency of the three nitrovasodilators was comparable; the veins were more sensitive to the effects of the dilators when contracted with prostaglandin F2 alpha than with either endothelin or norepinephrine. These results indicate that SIN-1, sodium nitroprusside, and NO are potent dilators of arterial and venous smooth muscle, and that the potency of the dilators can be altered by endothelial cells and the contractile agonist differentially in arteries and veins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2484703

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  Functional changes in nonadrenergic, noncholinergic inhibitory neurons in ileal circular smooth muscle after small bowel transplantation in rats.

Authors:  C Shibata; B M Balsiger; W J Anding; J A Duenes; V M Miller; M G Sarr
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

2.  Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.

Authors:  O Spreux-Varoquaux; J Doll; C Dutot; N Grandjean; P Cordonnier; M Pays; J Andrieu; C Advenier
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

Review 3.  The role of nitric oxide in cardiac surgery.

Authors:  Y Nonami
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.